Compound Evidence File
#EC-2026-0802
Melanotan II
Filed under Peptides. The bureau holds 239 laboratory returns for this compound from 62 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
62 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 21 Feb 2026 | 9 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 9.9 | 10.0 | 26 Mar 2026 | 12 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 9.9 | 10.0 | 24 Jan 2026 | 10 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 10.0 | 10.0 | 12 Apr 2026 | 23 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 22 Jan 2026 | 20 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Feb 2026 | 11 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 6 Apr 2026 | 18 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 10.0 | 10.0 | 14 Mar 2026 | 26 Jul 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 10.0 | 9.9 | 10.0 | 18 May 2026 | 18 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 15 Jun 2026 | 18 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 25 Jun 2026 | 2 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 9 Jan 2026 | 8 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 25 Mar 2026 | 10 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 9.9 | 9.9 | 10.0 | 1 May 2026 | 9 Aug 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 10.0 | 7 May 2026 | 1 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 9.9 | 9.9 | 10.0 | 27 Jun 2026 | 2 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 22 Jun 2026 | 22 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 9.9 | 11 Dec 2025 | 25 Mar 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 4 Jan 2026 | 8 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 9 May 2026 | 5 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 6 Jan 2026 | 24 May 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 4 Jun 2026 | 28 Jul 2026 |
| InjectifyCASE #VI-2026-0387 | A | 3 | 9.5 | 9.0 | 10.0 | 16 May 2025 | 14 Jun 2025 |
| UtherCASE #VI-2026-0902 | A | 2 | 9.2 | 9.1 | 9.2 | 9 Oct 2025 | 9 Oct 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.8 | 7.8 | 10.0 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 8.8 | 8.2 | 10.0 | 24 May 2026 | 24 May 2026 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | A | 3 | 8.8 | 6.5 | 10.0 | 10 Jul 2025 | 3 Oct 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 8 | 8.7 | 7.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 8.7 | 8.2 | 9.5 | 24 May 2026 | 24 May 2026 |
| Atomik LabzCASE #VI-2026-0327 | A | 4 | 8.4 | 7.4 | 9.0 | 8 May 2025 | 21 May 2025 |
| Eternal PeptidesCASE #VI-2026-0842 | A | 4 | 8.3 | 6.6 | 10.0 | 8 May 2025 | 21 May 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.1 | 7.3 | 9.6 | 24 May 2026 | 24 May 2026 |
| Pure RawzCASE #VI-2026-0767 | A | 4 | 8.1 | 7.4 | 9.2 | 8 May 2025 | 21 May 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | C | 6 | 7.6 | 4.5 | 10.0 | 18 Jul 2025 | 19 May 2026 |
| Nuscience PeptidesCASE #VI-2026-0554 | A | 6 | 7.5 | 6.9 | 8.5 | 22 Apr 2025 | 21 May 2025 |
| Planet PeptideCASE #VI-2026-0092 | B | 4 | 7.5 | 5.8 | 8.9 | 19 Feb 2025 | 19 Feb 2025 |
| HK PeptidesCASE #VI-2026-0140 | B | 9 | 7.3 | 5.7 | 10.0 | 16 Jul 2025 | 23 May 2026 |
| Elite Research USACASE #VI-2026-0267 | B | 5 | 7.3 | 5.7 | 8.0 | 16 May 2025 | 4 Aug 2025 |
| Xingruida XDRCASE #VI-2026-0898 | B | 2 | 7.3 | 5.7 | 8.8 | 18 Jul 2025 | 31 Jul 2025 |
| Amino AmigosCASE #VI-2026-0061 | B | 5 | 7.2 | 5.9 | 8.3 | 27 Feb 2025 | 20 Mar 2025 |
| Verified PeptidesCASE #VI-2026-0407 | B | 4 | 7.1 | 6.0 | 8.4 | 19 Feb 2025 | 19 Feb 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | B | 3 | 7.1 | 5.5 | 9.3 | 25 Apr 2025 | 8 May 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | B | 4 | 6.5 | 5.1 | 7.4 | 22 Apr 2025 | 16 May 2025 |
| DeuschemCASE #VI-2026-0004 | B | 4 | 6.4 | 5.9 | 7.1 | 14 Jun 2025 | 4 Aug 2025 |
| Peptide SciencesCASE #VI-2026-0867 | C | 10 | 6.4 | 4.2 | 8.3 | 19 Feb 2025 | 19 Feb 2025 |
| Skye PeptidesCASE #VI-2026-0451 | B | 4 | 6.3 | 5.1 | 7.5 | 27 Feb 2025 | 20 Mar 2025 |
| Precision Peptide CoCASE #VI-2026-0559 | C | 4 | 6.0 | 5.3 | 6.7 | 8 May 2025 | 16 May 2025 |
| ScienceCASE #VI-2026-0636 | C | 2 | 6.0 | 5.7 | 6.3 | 20 May 2025 | 20 May 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | C | 4 | 5.8 | 5.3 | 7.1 | 19 Feb 2025 | 19 Feb 2025 |
| Simple PeptideCASE #VI-2026-0782 | D | 3 | 5.5 | 4.0 | 7.9 | 25 Apr 2025 | 30 Apr 2025 |
| TydesCASE #VI-2026-0493 | C | 4 | 5.4 | 4.2 | 6.6 | 27 Feb 2025 | 20 Mar 2025 |
| Loti LabsCASE #VI-2026-0171 | C | 3 | 5.3 | 4.9 | 5.9 | 16 Mar 2025 | 16 Mar 2025 |
| Amino AsylumCASE #VI-2026-0828 | C | 2 | 5.3 | 5.2 | 5.4 | 19 Feb 2025 | 19 Feb 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | E | 4 | 5.3 | 1.7 | 8.0 | 10 Jun 2025 | 4 Aug 2025 |
| Peptide CraftersCASE #VI-2026-0994 | C | 4 | 5.1 | 4.6 | 5.5 | 27 Feb 2025 | 20 Mar 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | D | 2 | 4.8 | 4.8 | 4.8 | 21 May 2025 | 21 May 2025 |
| Platinum CryoCASE #VI-2026-0406 | E | 6 | 4.1 | 2.0 | 7.0 | 22 Apr 2025 | 8 May 2025 |
| Peptides For SaleCASE #VI-2026-0614 | E | 5 | 3.6 | 3.5 | 3.7 | 27 Feb 2025 | 20 Mar 2025 |
| Peptide GurusCASE #VI-2026-0854 | E | 3 | 2.2 | 2.0 | 2.7 | 16 Mar 2025 | 16 Mar 2025 |
| Accelerate LabsCASE #VI-2026-0686 | E | 2 | 2.0 | 2.0 | 2.0 | 16 May 2025 | 16 May 2025 |
Open any subject to view the batch-level evidence for Melanotan II alone.